Varma joined two new joint initiatives by investors
9.8.2024 11:00:26 EEST | Varma | Press release
Varma has joined a joint initiative by the UN-backed organisation for responsible investment PRI, which aims to prevent the possible negative impacts of social media and smart device use. The other joint initiative by investors relates to combating antibiotic overuse and antibiotic resistance.

The collaborative engagement on tech, mental health and wellbeing by the UN-backed organisation PRI involves 33 international investors who manage about 2400 billion euros in investments.
The initiative aims to raise awareness of the possible negative impacts of social media and technology device use on mental health and wellbeing. The international institutional investors involved believe that smart device use can have harmful effects on mental health. Studies show that screen overuse, especially at too early an age, can lead to concentration and behavioural disorders, the initiative's website states. Social media and device use are considered to expose users to addiction risks.
Investors classify these as ESG risks in the hardware, media, internet, gaming, software, and telecommunications sectors. The initiative seeks to commit companies to follow good practices and identify factors that cause addiction. The initiative also wants to ensure children's safety online and develop reporting of harmful sites.
Investors: Antibiotic resistance of viruses is a global threat
The second joint initiative (Investor Action on AMR Initiative) by investors aims to curb antibiotic resistance (AMR) caused by the overuse and misuse of antibiotics. Viruses and bacteria that have become resistant can resist the effects of drugs. This way they can continue to grow instead of being killed by antibiotics.
This is a significant health problem globally, as it complicates the treatment of infectious diseases, increases the length of hospital stays, raises treatment costs and mortality. In their petition, investors point out that AMR has been declared one of the ten biggest global threats to human health. In the joint initiative, investors seek to accelerate cooperation, make better use of existing experience and use shared resources to combat antibiotic resistance (AMR).
Antimicrobial residues also spread to the environment, which is why AMR has also become an environmental risk like climate change and biodiversity loss.
Contacts
Hanna Kaskela
Tel:040 584 5045hanna.kaskela@varma.fiMarjut Tervola
Tel:045 673 0120marjut.tervola@varma.fiLinks
Subscribe to releases from Varma
Subscribe to all the latest releases from Varma by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Varma
Varma rahoitti kotimaisia kasvuyrityksiä viidessä vuodessa yli miljardilla eurolla23.9.2026 08:52:59 EEST | Tiedote
Varma on rahoittanut vuoden 2021 alusta lähtien kotimaisia kasvuyrityksiä yli 1,1 miljardilla eurolla. Sijoituksilla Varma hakee eläkevaroille pitkäjänteistä tuottoa hajautetulla riskillä. Samalla sijoitukset tukevat suomalaisten yritysten kasvua ja kansainvälistymistä.
Varma provided over €1 billion in funding for Finnish growth companies in five years23.9.2026 08:52:59 EEST | Press release
Since the start of 2021, Varma has funded Finnish growth companies with around EUR 1.1 billion. These investments help Varma seek long-term returns on pension assets through risk diversification. At the same time, they support the growth and internationalisation of Finnish companies.
Varma tekee yli 50 miljoonan euron lisäsijoituksen Verdaan22.9.2026 10:12:47 EEST | Uutinen
Varma sijoittaa noin 51 miljoonaa euroa lisää tekoälypilvipalveluihin ja laskentakapasiteettiin erikoistuneeseen Verdaan. Tuoreen rahoituskierroksen jälkeen Varma jatkaa Verdan merkittävänä omistajana ja tukee suomalaisen yhtiön kansainvälistymistä. Suomeen syntyy rahoituskierroksen myötä uusi yksisarvinen eli miljardin dollarin arvoinen kasvuyhtiö.
Varma makes a follow-on investment of over EUR 50 million in cloud service provider Verda22.9.2026 10:12:47 EEST | News
Varma is making a follow-on investment of approximately EUR 51 million in Verda, a company specialising in AI cloud services and computing capacity. Following the latest funding round, Varma will remain a major shareholder in Verda and continue to support the Finnish company’s international growth. The funding round has created a new Finnish unicorn, a growth company valued at least USD 1 billion.
Ammatillisen kuntoutuksen palkallisuus hyödyttää sekä kuntoutujaa että työnantajaa21.9.2026 09:30:36 EEST | Tiedote
Varman tukema ammatillinen kuntoutus auttaa palaamaan työelämään sairauden jälkeen. Tyypillisimmin kuntoutus on omalla tai uudella työpaikalla tehtävää työkokeilua tai työhönvalmennusta. Kun kuntoutus toteutetaan palkallisena, se tukee kuntoutujan motivaatiota ja osallisuutta sekä lisää mahdollisuuksia työllistyä kuntoutusjakson jälkeen.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom